First experiences with intraoperative Levosimendan in pediatric cardiac surgery

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Pediatrics

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00431-008-0834-7PMID 18813947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass

  2007cited by this paper
• Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate

  2007cited by this paper
• Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.

  2007cited by this paper
• Early experience with Levosimendan in children with ventricular dysfunction*

  2006cited by this paper
• Correlation of oxygen delivery with central venous oxygen saturation, mean arterial pressure and heart rate in piglets

  2006cited by this paper
• Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.

  2004cited by this paper
• Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery

  2004cited by this paper
• Levosimendan interacts with potassium channel blockers in human saphenous veins.

  2004cited by this paper
• Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease

  2003cited by this paper
• Sustained Hemodynamic Effects of Intravenous Levosimendan

  2003cited by this paper
• What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure?

  2003cited by this paper
• An analysis of responses to levosimendan in the pulmonary vascular bed of the cat.

  2002cited by this paper
• An Analysis of Responses to Levosimendan in the Pulmonary Vascular Bed of the Cat

  2002cited by this paper
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

  2002cited by this paper
• Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure

  2002cited by this paper
• Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels

  2001cited by this paper
• Levosimendan is a mitochondrial K(ATP) channel opener.

  2001cited by this paper
• Levosimendan is a mitochondrial KATP channel opener

  2001cited by this paper
• Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

  1995cited by this paper
• Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.

  1995cited by this paper
• Cardiac performance and mortality early after intracardiac surgery in infants and young children.

  1975cited by this paper

• “Intracoronary levosimendan in neonatal cardiac surgery: a retrospective study on hemodynamic effects and catecholamine-sparing outcomes”

  2025cites this paper
• Efficacy of levosimendan therapy in pediatric practice: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Prophylactic use of levosimendan in preoperative setting for surgical repair of congenital heart disease in children

  2023cites this paper
• Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.

  2023cites this paper
• Safety of Levosimendan in Pediatric Patients: An Up-to-Date Systematic Review.

  2023cites this paper
• Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension

  2023cites this paper
• A systematic review of the evidence supporting post-operative medication use in congenital heart disease

  2021cites this paper
• Effect of Levosimendan Treatment in Pediatric Patients With Cardiac Dysfunction: An Update of a Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2021cites this paper
• An evidence-based review of the use of vasoactive and inotropic medications in post-operative paediatric patients after cardiac surgery with cardiopulmonary bypass from 2000 to 2020

  2020cites this paper
• APPENDIX A: Appendix: Pediatric Anesthesia Drugs and Other Treatments in the Perioperative Period

  2020cites this paper
• Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial

  2020cites this paper
• Cardiac Physiology and Pharmacology

  2019cites this paper
• Levosimendan: What Have We Learned So Far?

  2019cites this paper
• Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.

  2018cites this paper
• 16 – Critical Care

  2018cites this paper
• Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.

  2017cites this paper
• Critical Care in Pediatric Cardiac Surgery

  2017cites this paper
• Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.

  2017cites this paper
• تجویز پروفیلاکتیک لووسیمندان (levosimendan) برای پیشگیری از سندرم برونده پایین قلبی و مرگومیر در کودکان بیمار که تحت عمل جراحی برای بیماری قلبی مادرزادی قرار میگیرند

  2017cites this paper
• Vasodilator Agents in Pediatric Cardiac Surgery with Cardiopulmonary Bypass.

  2017cites this paper
• Levosimendan in Pediatric Cardiac Surgery: An Evidence Based Review

  2016cites this paper
• [Use of levosimendan in children].

  2016cites this paper
• Utilisation du levosimendan chez l’enfant

  2016cites this paper
• Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.

  2015cites this paper
• Experience with Levosimendan in 32 Paediatric Patients

  2015cites this paper
• A systematic review on levosimendan in paediatric patients.

  2015cites this paper
• Experience with Levosimendan in 32 Paediatric Patients

  2015cites this paper
• Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.

  2015cites this paper
• Perioperative use of levosimendan: best practice in operative settings.

  2013cites this paper
• Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?

  2013influential citation
• improves cerebral and systemic perfusion and oxygenation in critically ill neonates suffering from LCOS

  2013cites this paper
• Vasoactive compounds in the neonatal period.

  2012cites this paper
• Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study

  2012cites this paper
• [Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease].

  2012cites this paper
• Inotropic and vasoactive drugs in pediatric ICU.

  2012cites this paper
• Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.

  2012cites this paper
• Estudio descriptivo retrospectivo sobre la utilización de levosimendán en niños sometidos a corrección quirúrgica de cardiopatía congénita

  2012cites this paper
• Inotropic Support in the NICU: Ever More Compounds in Search of Guidance?

  2011cites this paper
• Prevention of Low Cardiac Output Syndrome in children: where is the evidence?

  2011cites this paper
• Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure

  2011cites this paper
• Differential Hemodynamic Effects of Levosimendan in a Porcine Model of Neonatal Hypoxia-Reoxygenation

  2011cites this paper
• Congenital Cardiac Surgery : A Randomized , Double-Blind Clinical Trial

  2011cites this paper
• Levosimendan in Two Neonates with Ischemic Heart Failure and Pulmonary Hypertension

  2011cites this paper
• [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].

  2011cites this paper
• Chapter 27 – Myocardial Dysfunction, Ventricular Assist Devices, and Extracorporeal Life Support

  2011cites this paper
• Appendix A: Pediatric Anesthesia Drugs and Other Treatments in the Perioperative Period

  2011cites this paper
• Acute Effects of Levosimendan on Cerebral and Systemic Perfusion and Oxygenation in Newborns: An Observational Study

  2010cites this paper
• The role of myocardial membrane proteins and myocardial oedema in postoperative myocardial dysfunction

  2009cites this paper